68 related articles for article (PubMed ID: 3228513)
1. [CA 15-3 in breast cancer--specificity and diagnostic potential].
Zito GA; Callipari S; Capuano S; Colella C; Cinque P; Gambardella A; Sacchettino A; Verza M; Varricchio M
Boll Soc Ital Biol Sper; 1988 Jul; 64(7):667-70. PubMed ID: 3228513
[No Abstract] [Full Text] [Related]
2. [Clinical evaluation of serum CA-50 measurement in breast diseases --relation to the progress of breast cancer].
Shiga T; Kawauchi A; Kamiya K; Ishii J; Uzawa R; Gomi K
Rinsho Byori; 1986 Nov; 34(11):1339-45. PubMed ID: 3469447
[No Abstract] [Full Text] [Related]
3. [CA 15-3 in breast cancer].
Zito GA; Callipari S; Capuano S; Tommasielli G; Pignatelli F; Varricchio M
Boll Soc Ital Biol Sper; 1988 Jul; 64(7):663-6. PubMed ID: 3228512
[No Abstract] [Full Text] [Related]
4. Comparison of ceruloplasmin and CA 15-3 in monitoring the clinical course of patients with breast cancer.
Ozyilkan O; Baltali E; Tekuzman G; Kars A; Firat D
Eur J Med; 1992 Sep; 1(5):318-9. PubMed ID: 1341619
[No Abstract] [Full Text] [Related]
5. [Clinical evaluation of a new tumor marker, CA 15-3, in breast cancer; a comparative study with CEA].
Komuro K; Watanabe K; Ishida T; Sakurai M; Amano R; Hagiwara H; Hara Y; Hanzawa T; Itsubo K
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3145-9. PubMed ID: 3465273
[TBL] [Abstract][Full Text] [Related]
6. Experience with CA 15.3 as a tumor marker in breast cancer.
Barros AC; Fry W; Nazario AC; Santos MO; Sato MK
Eur J Surg Oncol; 1994 Apr; 20(2):130-3. PubMed ID: 8181577
[TBL] [Abstract][Full Text] [Related]
7. [CA 15.3: Bayes' theorem].
Blasco R; Rodríguez Cortasa MJ; Barbero EM; Muñoz Calvo R
Med Clin (Barc); 1991 Jun; 97(1):38-9. PubMed ID: 1857147
[No Abstract] [Full Text] [Related]
8. [CA 15-3--a tumor marker in breast cancer].
Cohen AD; Cohen Y; Shoenfeld Y
Harefuah; 1993 Dec; 125(12):484-7. PubMed ID: 8112686
[No Abstract] [Full Text] [Related]
9. A comparative study of four serological tumor markers for the detection of breast cancer.
Clinton SR; Beason KL; Bryant S; Johnson JT; Jackson M; Wilson C; Holifield K; Vincent C; Hall M
Biomed Sci Instrum; 2003; 39():408-14. PubMed ID: 12724928
[TBL] [Abstract][Full Text] [Related]
10. CA 15.3: early results of a new breast cancer marker.
Colomer R; Sole LA; Navarro M; Encabo G; Ruibal A; Salvador L
Anticancer Res; 1986; 6(4):683-4. PubMed ID: 3463242
[TBL] [Abstract][Full Text] [Related]
11. Early diagnosis of breast cancer dissemination by tumor markers follow-up and method of prediction.
Nekulová M; Simícková M; Pecen L; Eben K; Vermousek I; Stratil P; Cernoch M; Lang B
Neoplasma; 1994; 41(2):113-8. PubMed ID: 8208314
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of serum tumour markers TPA, TPS, TAG 12, CA 15-3 and MCA in breast cancer diagnosis; results from a prospective study.
Eskelinen M; Hippeläinen M; Kettunen J; Salmela E; Penttilä I; Alhava E
Anticancer Res; 1994; 14(2B):699-703. PubMed ID: 8010729
[TBL] [Abstract][Full Text] [Related]
13. Serum marker combinations in human breast cancer (review).
Lamerz R; Stieber P; Fateh-Moghadam A
In Vivo; 1993; 7(6B):607-13. PubMed ID: 8193281
[TBL] [Abstract][Full Text] [Related]
14. CA 15-3, mucin-like carcinoma-associated antigen and tissue polypeptide-specific antigen: correlation to disease state and prognosis in breast cancer patients.
Cohen AD; Gopas J; Karplus G; Cohen Y
Isr J Med Sci; 1995; 31(2-3):155-9. PubMed ID: 7744585
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of a tumor-associated antigen CA 15-3 in the sera of patients with breast cancer].
Ogawa T; Izuo M; Morita H; Ishida T; Iino Y; Hoshino K; Yokoe T; Suzuki H; Murata S; Matsuzaki S
Gan No Rinsho; 1986 Jan; 32(1):27-32. PubMed ID: 3456454
[TBL] [Abstract][Full Text] [Related]
16. Clinical experience with the tumor marker Ca 19-9 in an unselected group of more than 300 tumor patients.
Souchon R; Koppenhagen K; Souchon MF; Matthes M; Boese-Landgraf J; Fitzner R; Baer U
Cancer Detect Prev; 1985; 8(1-2):101-9. PubMed ID: 3864534
[TBL] [Abstract][Full Text] [Related]
17. [CA 15-3 is present as a novel tumor marker in the sera of patients with breast cancer and other malignancies].
Gang Y; Adachi I; Ohkura H; Yamamoto H; Mizuguchi Y; Abe K
Gan To Kagaku Ryoho; 1985 Dec; 12(12):2379-86. PubMed ID: 3865634
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the new marker CA 549 versus CA 15-3 in neoplastic and non-neoplastic disease of the breast].
Di Seri M; Manna A; Sciò M; Marchei GG; De Benedetto A; Reale MG
J Nucl Med Allied Sci; 1990; 34(4 Suppl):49. PubMed ID: 2092149
[No Abstract] [Full Text] [Related]
19. Further studies on the detection of early lung and breast carcinoma by T antigen.
Springer GF; Fry WA; Desai PR; Semerdjian RA; Tegtmeyer H; Neybert CG; Scanlon EF
Cancer Detect Prev; 1985; 8(1-2):95-100. PubMed ID: 4064056
[TBL] [Abstract][Full Text] [Related]
20. [Tumor markers in the diagnosis and prognosis of breast cancer].
Seliuzhitskiĭ IV; Skvortsov SV; Lytsar BN; Khomenko LP
Klin Med (Mosk); 1993; 71(2):25-7. PubMed ID: 8046917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
